How has the absorbable hemostats market evolved, and where is it heading next?
The absorbable hemostats market size has grown strongly in recent years. It will grow from $23.59 billion in 2024 to $25.05 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to advances in surgical techniques, increasing prevalence of chronic diseases, rising demand for minimally invasive surgeries, improvements in hemostatic materials, and enhanced awareness of patient safety.
The absorbable hemostats market size is expected to see strong growth in the next few years. It will grow to $31.39 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to rising geriatric population, growing emphasis on personalized medicine, increasing healthcare expenditure, expansion of healthcare infrastructure, and rising incidence of trauma and emergencies. Major trends in the forecast period include development of multifunctional hemostatic products, integration of smart technologies for real-time monitoring, growing use of bioengineered materials, rise in partnerships and collaborations, and advancements in regulatory standards.
Get Your Free Sample of The Global Absorbable Hemostats Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18777&type=smp
What are the key drivers behind the rapid expansion of the absorbable hemostats market?
The increasing number of surgical procedures is expected to drive the growth of the absorbable hemostats market going forward. Surgical procedures are medical operations performed to treat, diagnose, or manage conditions by physically altering tissues or organs through incisions or other techniques. The increase in surgical procedures is due to increasing demand for advanced medical treatments, an aging population, and advancements in surgical technology that enable more complex and minimally invasive operations. Absorbable hemostats are used for surgical procedures to control bleeding and promote clot formation while being gradually absorbed by the body, reducing the need for additional interventions and minimizing postoperative complications. For instance, in March 2023, according to the British Association of Aesthetic Plastic Surgeons, a UK-based surgical organization, there were 31,057 cosmetic procedures in 2022, marking a 102% increase from the previous year. Therefore, the increasing number of surgical procedures is driving the growth of the absorbable hemostasis market.
What is the segmentation for the absorbable hemostats market?
The absorbable hemostats market covered in this report is segmented –
1) By Type: Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Other Types
2) By Application: Neurosurgery, Orthopedic Surgery, General Surgery, Reconstructive Surgery, Other Applications
3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Thrombin-Based Hemostats: Lyophilized Thrombin Hemostats, Liquid Thrombin-Based Hemostats
2) By Oxidized Regenerated Cellulose-Based Hemostats: Pre-Packaged Oxidized Cellulose Hemostats, Customizable Oxidized Cellulose Products
3) By Gelatin-Based Hemostats: Gelatin Sponge-Based Hemostats, Gelatin Foam-Based Hemostats
4) By Collagen-Based Hemostats: Collagen-Based Pads or Sheets, Collagen-Based Sponges or Powder
5) By Other Types: Fibrin-Based Hemostats, Polymeric-Based Hemostats, Other Innovative Or Hybrid Formulations
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report
Who are the most influential companies in the absorbable hemostats market?
Major companies operating in the absorbable hemostats market are Johnson & Johnson, Medtronic Plc, Becton, Dickinson and Company, Stryker Corporation, Baxter International Inc., CSL Behring, B. Braun Melsungen AG, Teleflex Incorporated, Samyang Holdings Corporation, Integra LifeSciences, Acelity, Meril Life Sciences Pvt. Ltd., Gelita AG, CryoLife Inc., Anika Therapeutics Inc., Z-Medica LLC, Cohera Medical Inc., Marine Polymer Technologies Inc., Curasan AG, Hemostasis LLC, Arch Therapeutics Inc., Cura Medical, Ferrosan Medical Devices A/S, FzioMed Inc., Guizhou Jin Jiu Biotech Co. Ltd.
What are the most influential trends expected to drive the absorbable hemostats market forward?
Major companies in the absorbable hemostats market are focused on developing advanced products, such as absorbable hemostatic powder, to provide rapid and effective bleeding control during surgery. The absorbable hemostatic powder is a medical product used to control bleeding by promoting rapid clot formation at the site of injury, and the body naturally absorbs it after fulfilling its function. For instance, in July 2023, Baxter International Inc., a US-based healthcare company, launched PERCLOT absorbable hemostatic powder. PERCLOT granules possess a unique molecular structure that rapidly absorbs water, forming a gelled adhesive matrix that creates a mechanical barrier to stop bleeding by promoting the accumulation of platelets, red blood cells, and coagulation proteins like thrombin and fibrinogen. This feature enhances clinicians’ ability to manage a broader range of intraoperative bleeding, which is crucial in reducing the need for blood transfusions, minimizing major complications, and ultimately lowering the overall cost of care.
What are the major regional insights for the absorbable hemostats market, and which region holds the top position?
North America was the largest region in the absorbable hemostats market in 2024. The regions covered in the absorbable hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Absorbable Hemostats Market Report 2025 Offer?
The absorbable hemostats market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
An absorbable hemostat is a medical device used to control bleeding during surgical procedures. It is designed to promote blood clotting and stabilize hemorrhaging tissues. An absorbable hemostat is made from materials that can be gradually broken down and absorbed by the body over time, eliminating the need for surgical removal.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18777
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
